NCT00940992

A Study of DER 45-EV Gel to Treat Rosacea

A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Dose-Range Study of DER 45 EV Gel, 1% and 5%, and Vehicle Gel in the Treatment of Rosacea

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 92 (actual)
• Sponsor: Sol-Gel Technologies, Ltd. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To identify lowest efficacious dose of DER 45 EV Gel, 1% and 5% verses vehicle in patients with rosacea.

Conditions

• Rosacea

Interventions

Type	Name	Description
DRUG	DER 45 EV	Topical application to face for 12 weeks
DRUG	Vehicle	Topical application to face for 12 weeks

Timeline

• Start date: 2012-01-01
• Primary completion: 2012-09-01
• Completion: 2013-01-01
• First posted: 2009-07-17
• Last updated: 2015-01-09
• Results posted: 2015-01-09

Locations

10 sites across 1 country: United States